Patent · US Expired

Engineered superantigen for human therapy

US7125554B2 · kind B2 · utility

54Cited by

20References

49Claims

0Family size

Assignee

Active Biotech AB · SE

Inventors

Goran Forsberg · Karlstad, SE
Eva Erlandsson · Dalby, SE
Per Antonsson · Malmö, SE
Björn Walse · Lund, SE

Key dates

Filing date	Jul 6, 2001
Grant date	Oct 24, 2006
Priority date	—
Expiry date	Jul 6, 2021

Classification

Technology area (CPC H)Electricity
CPC primaryH04L51/58
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to compositions and methods of use, wherein the composition comprises a conjugate of a bacterial superantigen and an antibody moiety. More particularly, the bacterial superantigen has been modified to decrease seroreactivity with retained superantigen activity.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.